Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Cord Stimulation | 25 | 2026 | 47 | 8.410 |
Why?
|
| Diabetic Neuropathies | 8 | 2025 | 57 | 4.960 |
Why?
|
| Pain Management | 18 | 2026 | 185 | 3.430 |
Why?
|
| Chronic Pain | 18 | 2026 | 183 | 3.360 |
Why?
|
| Diabetes Mellitus | 5 | 2023 | 321 | 2.560 |
Why?
|
| Pain Measurement | 8 | 2025 | 259 | 1.260 |
Why?
|
| Electric Stimulation Therapy | 5 | 2023 | 23 | 1.230 |
Why?
|
| Deep Brain Stimulation | 8 | 2020 | 42 | 1.110 |
Why?
|
| Neuralgia | 4 | 2024 | 44 | 0.920 |
Why?
|
| Treatment Outcome | 22 | 2026 | 5595 | 0.880 |
Why?
|
| Neurosurgical Procedures | 7 | 2022 | 137 | 0.820 |
Why?
|
| Complex Regional Pain Syndromes | 2 | 2020 | 13 | 0.810 |
Why?
|
| Disabled Persons | 1 | 2023 | 73 | 0.740 |
Why?
|
| Faculty | 1 | 2020 | 71 | 0.640 |
Why?
|
| Anesthesiology | 1 | 2020 | 37 | 0.640 |
Why?
|
| Education, Distance | 1 | 2020 | 43 | 0.630 |
Why?
|
| Humans | 50 | 2026 | 53230 | 0.620 |
Why?
|
| Quality of Life | 9 | 2025 | 902 | 0.610 |
Why?
|
| Stereotaxic Techniques | 4 | 2022 | 41 | 0.600 |
Why?
|
| Subthalamic Nucleus | 4 | 2011 | 12 | 0.580 |
Why?
|
| Pandemics | 2 | 2020 | 595 | 0.500 |
Why?
|
| Parkinson Disease | 4 | 2011 | 156 | 0.490 |
Why?
|
| Pedunculopontine Tegmental Nucleus | 1 | 2014 | 24 | 0.430 |
Why?
|
| Peripheral Nerves | 1 | 2014 | 43 | 0.420 |
Why?
|
| Middle Aged | 17 | 2026 | 13419 | 0.420 |
Why?
|
| Back Pain | 3 | 2025 | 40 | 0.410 |
Why?
|
| Aged | 12 | 2026 | 10429 | 0.390 |
Why?
|
| Follow-Up Studies | 3 | 2025 | 2318 | 0.390 |
Why?
|
| Balamuthia mandrillaris | 1 | 2012 | 2 | 0.380 |
Why?
|
| Pain | 3 | 2023 | 351 | 0.380 |
Why?
|
| Amebiasis | 1 | 2012 | 6 | 0.380 |
Why?
|
| Granuloma | 1 | 2012 | 46 | 0.370 |
Why?
|
| Encephalitis | 1 | 2012 | 40 | 0.370 |
Why?
|
| Adult | 15 | 2026 | 14534 | 0.360 |
Why?
|
| Ganglia, Spinal | 3 | 2020 | 50 | 0.340 |
Why?
|
| Prospective Studies | 5 | 2025 | 2411 | 0.320 |
Why?
|
| Female | 18 | 2026 | 28782 | 0.310 |
Why?
|
| Failed Back Surgery Syndrome | 2 | 2021 | 2 | 0.310 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2022 | 1583 | 0.310 |
Why?
|
| Male | 17 | 2026 | 27435 | 0.310 |
Why?
|
| Spinal Cord | 6 | 2025 | 130 | 0.290 |
Why?
|
| Electrodes, Implanted | 7 | 2026 | 36 | 0.280 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 502 | 0.250 |
Why?
|
| Salvage Therapy | 2 | 2024 | 138 | 0.240 |
Why?
|
| Resilience, Psychological | 1 | 2025 | 34 | 0.220 |
Why?
|
| Pain, Intractable | 1 | 2024 | 5 | 0.210 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2025 | 630 | 0.210 |
Why?
|
| Nerve Block | 1 | 2024 | 42 | 0.210 |
Why?
|
| Cross-Over Studies | 1 | 2024 | 241 | 0.200 |
Why?
|
| Referral and Consultation | 1 | 2025 | 299 | 0.200 |
Why?
|
| Injections, Spinal | 2 | 2020 | 22 | 0.190 |
Why?
|
| Delivery of Health Care | 1 | 2025 | 317 | 0.190 |
Why?
|
| Health Care Costs | 1 | 2023 | 178 | 0.190 |
Why?
|
| Health Personnel | 1 | 2025 | 259 | 0.180 |
Why?
|
| Medicare | 1 | 2023 | 280 | 0.170 |
Why?
|
| Evidence-Based Medicine | 3 | 2017 | 275 | 0.170 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2021 | 12 | 0.170 |
Why?
|
| Sex Factors | 2 | 2020 | 747 | 0.170 |
Why?
|
| Drug Delivery Systems | 2 | 2020 | 148 | 0.170 |
Why?
|
| Health Occupations | 1 | 2020 | 19 | 0.170 |
Why?
|
| Industry | 1 | 2020 | 16 | 0.170 |
Why?
|
| Neurosurgery | 2 | 2018 | 36 | 0.160 |
Why?
|
| Critical Pathways | 1 | 2020 | 36 | 0.160 |
Why?
|
| Physicians, Women | 1 | 2020 | 20 | 0.160 |
Why?
|
| Physicians | 1 | 2023 | 242 | 0.150 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2023 | 379 | 0.150 |
Why?
|
| Neurology | 1 | 2020 | 33 | 0.150 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 124 | 0.150 |
Why?
|
| Societies, Medical | 1 | 2020 | 207 | 0.150 |
Why?
|
| Off-Label Use | 1 | 2019 | 24 | 0.150 |
Why?
|
| Physician's Role | 1 | 2019 | 49 | 0.150 |
Why?
|
| Social Media | 1 | 2020 | 125 | 0.140 |
Why?
|
| Faculty, Medical | 1 | 2019 | 92 | 0.140 |
Why?
|
| Headache | 2 | 2015 | 75 | 0.140 |
Why?
|
| Career Choice | 1 | 2019 | 116 | 0.140 |
Why?
|
| Internet | 1 | 2020 | 265 | 0.140 |
Why?
|
| General Surgery | 1 | 2019 | 108 | 0.140 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 177 | 0.130 |
Why?
|
| Students, Medical | 1 | 2019 | 157 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 188 | 0.130 |
Why?
|
| Movement Disorders | 2 | 2014 | 17 | 0.130 |
Why?
|
| United States | 3 | 2023 | 5409 | 0.130 |
Why?
|
| Evoked Potentials | 2 | 2022 | 67 | 0.130 |
Why?
|
| Spinal Nerves | 1 | 2015 | 7 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 1723 | 0.110 |
Why?
|
| Implantable Neurostimulators | 1 | 2014 | 1 | 0.110 |
Why?
|
| Headache Disorders | 1 | 2014 | 3 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2019 | 439 | 0.110 |
Why?
|
| Migraine Disorders | 1 | 2014 | 46 | 0.100 |
Why?
|
| Consensus | 2 | 2025 | 206 | 0.100 |
Why?
|
| Action Potentials | 2 | 2024 | 116 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2018 | 446 | 0.100 |
Why?
|
| Double-Blind Method | 2 | 2024 | 729 | 0.090 |
Why?
|
| Neurologic Examination | 1 | 2012 | 75 | 0.090 |
Why?
|
| Steroids | 1 | 2012 | 61 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2012 | 193 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 452 | 0.090 |
Why?
|
| Parietal Bone | 1 | 2011 | 2 | 0.090 |
Why?
|
| Neuronavigation | 1 | 2010 | 11 | 0.080 |
Why?
|
| Pneumocephalus | 1 | 2010 | 4 | 0.080 |
Why?
|
| Biopsy | 1 | 2012 | 600 | 0.080 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2010 | 54 | 0.080 |
Why?
|
| Anesthesia | 1 | 2010 | 67 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 975 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2010 | 547 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2023 | 1219 | 0.070 |
Why?
|
| Adolescent | 1 | 2020 | 6907 | 0.070 |
Why?
|
| Child | 1 | 2020 | 7379 | 0.070 |
Why?
|
| Vagus Nerve Stimulation | 2 | 2020 | 15 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 1180 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 830 | 0.060 |
Why?
|
| Analgesics | 2 | 2019 | 104 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2026 | 6819 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 1 | 2025 | 114 | 0.060 |
Why?
|
| Delphi Technique | 1 | 2025 | 71 | 0.060 |
Why?
|
| Leadership | 1 | 2025 | 106 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2024 | 120 | 0.050 |
Why?
|
| Demography | 1 | 2024 | 91 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2024 | 169 | 0.050 |
Why?
|
| Brain | 1 | 2010 | 1350 | 0.050 |
Why?
|
| Patch Tests | 1 | 2021 | 6 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2022 | 145 | 0.040 |
Why?
|
| International Classification of Diseases | 1 | 2021 | 70 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2021 | 54 | 0.040 |
Why?
|
| Erythema | 1 | 2021 | 38 | 0.040 |
Why?
|
| Spine | 1 | 2021 | 87 | 0.040 |
Why?
|
| Young Adult | 1 | 2010 | 4511 | 0.040 |
Why?
|
| Device Removal | 1 | 2021 | 89 | 0.040 |
Why?
|
| Curriculum | 1 | 2023 | 409 | 0.040 |
Why?
|
| Patient Safety | 1 | 2020 | 103 | 0.040 |
Why?
|
| Animals | 1 | 2014 | 13526 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 93 | 0.040 |
Why?
|
| Health Status | 1 | 2020 | 306 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 622 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 2991 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 4017 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 1368 | 0.030 |
Why?
|
| Reoperation | 1 | 2017 | 476 | 0.030 |
Why?
|
| Facial Pain | 1 | 2014 | 10 | 0.030 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2014 | 72 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2014 | 138 | 0.020 |
Why?
|
| Patient Selection | 1 | 2014 | 273 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2014 | 280 | 0.020 |
Why?
|
| Microelectrodes | 1 | 2010 | 17 | 0.020 |
Why?
|
| Beta Rhythm | 1 | 2010 | 2 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2010 | 19 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2010 | 103 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2010 | 46 | 0.020 |
Why?
|
| Software | 1 | 2010 | 280 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 1049 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2010 | 1099 | 0.010 |
Why?
|